Macrolide, Lincosamide, Streptogramin, Ketolide, and Oxazolidinone Resistance

Marilyn C. Roberts; Joyce Sutcliffe

doi:10.1128/9781555817572.ch6

Chapter 6 : Macrolide, Lincosamide, Streptogramin, Ketolide, and Oxazolidinone Resistance

Authors: Marilyn C. Roberts¹, Joyce Sutcliffe³

VIEW AFFILIATIONS HIDE AFFILIATIONS

Affiliations: 1: Department of Pathobiology, Box 357238, University of Washington, Seattle, WA 98195; 2: Department of Pathobiology, Box 357238, University of Washington, Seattle, WA 98195; 3: Rib-X Pharmaceuticals, Inc., New Haven, CT 06511

Content Type: Monograph

Publication Year: 2005

Category: Bacterial Pathogenesis

Book DOI: 10.1128/9781555817572

Chapter DOI: 10.1128/9781555817572.ch6

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:

Macrolide, Lincosamide, Streptogramin, Ketolide, and Oxazolidinone Resistance, Page 1 of 2

< Previous page | Next page > /docserver/preview/fulltext/10.1128/9781555817572/9781555813291_Chap06-1.gif /docserver/preview/fulltext/10.1128/9781555817572/9781555813291_Chap06-2.gif

Abstract:

Macrolides, lincosamides, streptogramins, ketolides, and oxazolidinones (MLSKO), though chemically distinct, share overlapping binding sites on the 50S subunit of the ribosome. Bacteria acquire resistance to one or more of these antibiotics by the acquisition of a gene(s) or with certain mutations. The ketolides are macrolide derivatives that have recently become available for human therapy. The lincosamides are a distinct group of antibiotics that are structurally unrelated to macrolides. The streptogramin B component shares an overlapping ribosomal binding site, on the 50S ribosomal subunit, with the macrolides and lincosamides and is impacted by erm methylation at A2058 (Escherichia coli numbering). The MLSKO antibiotics inhibit protein synthesis by binding to the 50S ribosomal subunit and blocking peptide bond formation and/or translation. The binding of 14-, 15-, and 16-membered macrolides, clindamycin, and two ketolides has been described in this chapter. The Mycobacterium erm genes are regulated at the translation step. These genes confer resistance to macrolides and lincosamides but not to streptogramin B. Mutations associated with resistance to macrolides, ketolides, streptogramins, or oxazolidinones have been described in the chapter. However, with the addition of the newer macrolides, streptogramins, ketolides, and oxazolidinones, use of this group of antibiotics has increased, and today they are important in the treatment of a variety of infectious diseases in both community and hospital environments. Ketolide resistance in streptococci and oxazolidinone resistance in gram-positive enterococci or staphylococci are surfacing with increased therapeutic use.

Citation: Roberts M, Sutcliffe J. 2005. Macrolide, Lincosamide, Streptogramin, Ketolide, and Oxazolidinone Resistance, p 66-84. In White D, Alekshun M, McDermott P (ed), Frontiers in Antimicrobial Resistance. ASM Press, Washington, DC. doi: 10.1128/9781555817572.ch6

Key Concept Ranking

Mobile Genetic Elements: 0.5427135
Antibacterial Agents: 0.50681233
Major Facilitator Superfamily: 0.50267816
Amino Acid Addition: 0.472954

0.5427135

Highlighted Text: Show | Hide

Full text loading...

Figures

Macrolide, Lincosamide, Streptogramin, Ketolide, and Oxazolidinone Resistance

[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817572.chap6-1,webId=/content/author/10.1128/9781555817572.chap6-1,properties={foaf_givenname=Marilyn C., foaf_name=Marilyn C. Roberts, foaf_surname=Roberts, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817572.chap6-aff1]]}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555817572.chap6-2,webId=/content/author/10.1128/9781555817572.chap6-2,properties={foaf_givenname=Joyce, foaf_name=Joyce Sutcliffe, foaf_surname=Sutcliffe, pub_isAffiliatedWith=[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/affiliation/10.1128/9781555817572.chap6-aff3]]}]]

/content/10.1128/9781555817572.chap6.fig6-1

Figure 1a

Structures of the various MLSKO antibiotics. (Continued on following page.)

10.1128/9781555817572/fig6-1a_thmb.gif

10.1128/9781555817572/fig6-1a.gif

Figure 1a

Structures of the various MLSKO antibiotics. (Continued on following page.)

/content/10.1128/9781555817572.chap6.fig6-1b

Figure 1b

Structures of the various MLSKO antibiotics. (Continued on following page.)

10.1128/9781555817572/fig6-1b_thmb.gif

10.1128/9781555817572/fig6-1b.gif

Figure 1b

Structures of the various MLSKO antibiotics. (Continued on following page.)

References

/content/book/10.1128/9781555817572.chap6

1. Allignet, J.,, and N. El Solh. 1995. Diversity among the gram-positive acetyltransferases inactivating streptogramin A and structurally related compounds and characterization of a new staphylococcal determinant, vatB. Antimicrob. Agents Chemother. 39: 2027– 2036.

2. Allignet, J.,, and N. El Solh. 1999. Comparative analysis of staphylococcal plasmids carrying three streptogramin-resistance genes: vat-vgb-vga. Plasmid 42: 134– 138.

3. Allignet, J.,, N. Liassine,, and N. El Solh. 1998. Characterization of a staphylococcal plasmid related to pUB110 and carrying two novel genes, vatC and vgbB, encoding resistance to streptogramins A and B and similar antibiotics. Antimicrob. Agents Chemother. 42: 1794– 1798.

4. Allignet, J.,, V. Loncle,, C. Simenel,, M. Delepierre,, and N. El Solh. 1993. Sequence of a staphylococcal gene, vat, encoding an acetyltransferase inactivating the A-type compounds of virginiamycin-like antibiotics. Gene 130: 91– 98.

5. Alonso, A.,, P. Sanchezm,, and J. L. Marinez. 2000. Stenotrophomonas maltophilia D457R contains a cluster of genes from gram-positive bacteria involved in antibiotic and heavy metal resistance. Antimicrob. Agents Chemother. 44: 1778– 1782.

6. Amsden, G.W. 2001. Advanced-generation macrolides: tissuedirected antibiotics. Inter. J. Antimicrob. Agents 18: S11– S15.

7. Arthur, M.,, A. Andremont,, and P. Courvalin. 1987. Distribution of erythromycin esterase and rRNA methylase genes in members of the family Enterobacteriaceae highly resistant to erythromycin. Antimicrob. Agents Chemother. 31: 404– 409.

8. Atkinson, B. A.,, A. Abu-Al-Jaibat,, and D. J. LeBlanc. 1997. Antibiotic resistance among enterococci isolated from clinical specimens between 1953 and 1954. Antimicrob. Agents Chemother. 41: 1598– 1600.

9. Aumercier, M.,, S. Bouchallab,, M. L. Capmau,, F. Le Goffic. 1992. RP59500: a proposed mechanism for its bacterial activity. J. Antimicrob. Chemother. 30: 9– 14.

10. Banks, D. J.,, S. F. Porcella,, K. D. Barbian,, J. M. Martin,, and J. M. Musser. 2003. Structure and distribution of an unusual chimeric genetic element encoding macrolide resistance in phylogenetically diverse clones of group A Streptococcus. J. Infect. Dis. 188: 1898– 1908.

11. Bartkus, J. M.,, A. Juni,, K. Ehresmann,, C. A. Miller,, G. N. Sanden,, P. K. Cassiday,, M. Saubolle,, B. Lee,, J. Long,, A. R. Harrison, Jr., and J. M. Besser. 2003. Identification of a mutation associated with erythromycin resistance in Bordetella pertussis: implications for surveillance of antimicrobial resistance. J. Clin. Microbiol. 41: 1167– 1172.

12. Berisio, R.,, J. Harms,, F. Schluenzen,, R. Zarivach,, H. A. Hansen,, P. Fucini,, and A. Yonath. 2003. Structural insight into the antibiotic action of telithromycin against resistant mutants. J. Bacteriol. 185: 4276– 4279. Erratum In J. Bacteriol. 185: 5027.

13. Besier, S.,, K.-P. Hunfeld,, I. Giesser,, V. Schafer,, V. Brade,, and T. A. Wichelhaus. 2003. Selection of ketolide resistance in Staphylococcus aureus. Int. J. Antimicrob. Agents 22: 87– 88.

14. Biskri, L.,, and D. Mazel. 2003. Erythromycin esterase gene ere(A) is located in a functional gene cassette in an unusual class 2 integron. Antimicrob. Agents Chemother. 47: 3326– 3331.

15. Bozdogan, B.,, L. Berrezouga,, M.-S. Kuo,, D. A. Yurek,, K. A. Farley,, B. J. Stockman,, and R. Leclercq. 1999. A new resistance gene, linB, conferring resistance to lincosamides by nucleotidylation in Enterococcus faecium HM1025. Antimicrob. Agents Chemother. 43: 925– 929.

16. Bozdogan, B.,, S. Galopin,, and R. Leclercq. 2004. Characterization of a new erm-related macrolide resistance gene present in probiotic strains of Bacillus clausii. Appl. Environ. Microbiol. 70: 280– 284.

17. Bozdogan, B.,, P. C. Appelbaum,, L. Ednie,, I. N. Grivea,, and G. A. Syrogiannopoulos. 2003. Development of macrolide resistance by ribosomal protein L4 mutation in Streptococcus pyogenes during miocamycin treatment of an eight-year-old Greek child with tonsillopharyngitis. Clin. Microbiol. Infect. 9: 966– 969.

17a.. Bozdogan, Eg,, P. C. Appelbaum,, L. M. Kelly,, D. B. Hoellman,, A. Tambic-Andrasevic,, L. Drukalska,, W. Hryniewicz,, H. Hupkova,, M. R. Jacobs,, J. Kolman,, M. Konkoly-Thege,, J. Miciuleviciene,, M. Pana,, L. Setchanova,, J. Trupl,, and P. Urbaskova. 2004. Activity of telithromycin compared with seven other agents against 1039 Streptococcus pyogenes pediatric isolates from ten centers in Central and Eastern Europe. Clin. Microbiol. Infect. 9: 741– 745.

17b.. Bozdogan, B.,, M. V. Patel,, S. V. Gupte,, N. de Souza,, H. Khorakiwala,, K. Sreenivas. 2002. Characterization of linezoid resistant mutants of Staphylococcus aureus and Streptococcus pneumoniae isolated from mouse in terms of 23S rRNA mutations, abstr. C1, p. 1609. In Proceedings of the 42nd Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.

18. Brenciani, A.,, K. K. Ojo,, A. Monachetti,, S. Menzo,, M. C. Roberts,, P. E. Varaldo,, and E. Giovanetti. 2004. Distribution and molecular analysis of mef(A)-containing elements in tetracycline- susceptible and -resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. J. Antimicrob. Chemother. 54: 991– 998.

18a.. Brook, I., and K. Shah. 2003. Effect of amoxicillin or clindamycin on the adenoids bacterial flora. Otolary. Head Neck Surg. 129: 5– 10.

19. Bryskier, A.,, and A. Denis,. 2001. Ketolides: novel antibacterial agents designed to overcome resistance to erythromycin A within gram-positive cocci, p 97– 140. In W. Schonfeld, and H. A. Kirst (ed.), Macrolide Antibiotics. Birkhauser Verlag, Basel, Switzerland.

20. Camps, M.,, G. Arrizabalaga,, and J. Boothroyd. 2002. An rRNA mutation identifies the apicoplast as the target for clindamycin in Toxoplasma gondii. Mol. Microbiol. 43: 1309– 1328.

21. Canu, A.,, B. Malbruny,, M. Coquemont,, T. A. Davies,, P. C. Appelbaum,, and R. Leclercq. 2002. Diversity of ribosomal mutations conferring resistance to macrolides, clindamycin, streptogramin, and telithromycin in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46: 125– 131.

22. Carfartan, G.,, P. Gerardin,, D. Turck,, and M.-O. Husson. 2004. Effect of subinhibitory concentrations of azithromycin on adherence of Pseudomonas aeruginosa to bronchial mucins collected from cystic fibrosis patients. J. Antimicrob. Chemother. 53: 686– 688.

23. Cheng, J.,, T. Grege,, L. Wondrack,, P. Courvalin,, and J. Sutcliffe. 1999. Characterization of genes involved in erythromycin resistance in a clinical strain of Staphylococcus aureus. In Abstract of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy, #83, p. 114, San Francisco, Calif.

24. Chung, W. O.,, C. Werckenthin,, S. Schwarz,, and M. C. Roberts. 1999. Host range of the ermF rRNA methylase gene in human and animal bacteria. J. Antimicrob. Chemother. 43: 5– 14.

25. Cousin, S. L., Jr., W. L. Whittington, and M. C. Roberts. 2003. Acquired macrolide resistance genes and the 1 bp deletion in the mtrR promoter in Neisseria gonorrhoeae. J. Antimicrob. Chemother. 51: 131– 133.

26. Cousin, S. L., Jr.,, W. L. Whittington,, and M. C. Roberts. 2003. Acquired macrolide resistance genes in pathogenic Neisseria spp. Isolated between 1940 and 1987. Antimicrob. Agents Chemother. 47: 3877– 3880.

27. Daly, M.,, R. Flamm,, and V. Shortridge. 2003. The prevalence of mef(A) vs mef(E) in S. pneumoniae and the characterization of associated msr(A) homolog element. In Abstract of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, C2-71, p. 112, Chicago Ill.

28. Del Grosso, M.,, A. C. d’Abusco,, F. Iannelli,, G. Pozzi,, and A. Panatosti. 2004. Tn 2009, a Tn 916-like element containing mef(E) in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 48: 2037– 2042.

29. De Meester, C.,, and J. Rondelet. 1976. Microbial acetylation of M factor of virginiamycin. J. Antibio. 29: 1297– 1305.

30. Depardieu, F.,, and P. Courvalin. 2001. Mutation in 23S rRNA responsible for resistance to 16-membered macrolides and streptogramins in Streptococcus pneumnoniae. Antimicrob. Agents Chemother. 45: 319– 323.

31. Dixon, J. 1967. Pneumococcus resistant to erythromycin and lincomycin. Lancet 1: 573.

32. Douthwaite, S. 2003. Differentiating macrolide and ketolide interactions: implications for resistance, abst. 1333, p. 524. In Program and Abstracts of the 43rd Interscience Conference on Antimicrobial Agents and Chemotherapy, American Society for Microbiology, Washington, D.C.

33. Edlund, C.,, E. Sillerstrom,, E. Wahlund,, and C. E. Nord. 1998. In vitro activity of HMR 3647 against anaerobic bacteria. J. Chemoth. 10: 280– 284.

34. Farrell, D. J.,, S. Douthwaite,, I. Morrissey,, S. Bakker,, J. Poehlsgaard,, L. Jakobsen,, and D. Felmingham. 2003. Macrolide resistance by ribosomal mutation in clinical isolates of Streptococcus pneumoniae from the PROTEKT 1999-2000 study. Antimicrob. Agents Chemother. 47: 1777– 1783.

34a.. Farrell, D. J.,, I. Morrissey,, S. Bakker,, S. Buckridge,, and D. Felmingham. 2004. In vitro activities of telithromycin, linezolid, and quinupristin-dalfopristin against Streptococcus pneumoniae with macrolide resistance due to ribosomal mutations. Antimicrob. Agents Chemother. 48: 3169– 3171.

34b.. Franceschi, F.,, Z. Kanyo,, E. C. Sherer,, and J. Sutcliffe. Macrolide resistance from the ribosome perspective. Curr. Drug Targets Infect. Disord. 4: 177– 191.

35. Furneri, P. M.,, G. Rappazzo,, M. P. Musumarra,, P. D. Pietro,, L. S. Catania,, and L. S. Roccasalva. 2001. Two new point mutations at A2062 associated with resistance to 16-membered macrolide antibiotics in mutant strains of Mycoplasma hominis. Antimicrob. Agents Chemother. 45: 2958– 2960.

36. Garcia-Rodriquez, J. A.,, J. E. Garcia-Sanchez,, and J. L. Munoz-Bellido. 1995. Antimicrobial resistance in anaerobic bacteria: current situation. Anaerobe 1: 69– 80.

37. Garza-Ramos, G.,, L. Xiong,, P. Zhong,, and A. Mankin. 2001. Binding site of macrolide antibiotics on the ribosome: new resistance mutation identifies a specific interaction of ketolides with rRNA. J. Bacteriol. 184: 6898– 6907.

38. Giovanetti, E.,, A. Brenciani,, R. Lupidi,, M. C. Roberts,, and P. E. Varaldo. 2003. The presence of the tet(O) gene in erythromycin and tetracycline-resistant strains of Streptococcus pyogenes. Antimicrob. Agents Chemother. 47: 2844– 2849.

39. Gonzales, R. D.,, P. C. Schreckenberger,, M. B. Graham,, S. Kelkar,, K. DenBesten,, and J. P. Quinn. 2001. Infections due to vancomycin-resistant Enterococcus faecium resistant to linezolid. Lancet 357: 1179.

40. Gupta, A.,, H. Vlamakis,, N. Shoemaker,, and A. A. Salyers. 2003. A new Bacteroides conjugative transposon that carries an ermB gene. Appl. Environ. Microbiol. 69: 6455– 663.

41. Hammerum, A. M.,, S. E. Flannagan,, D. B. Clewell,, and L. B. Jensen. 2001. Indication of transposition of a mobile DNA element containing the vat(D) and erm(B) genes in Enterococcus faecium. Antimicrob. Agents Chemother. 45: 3223– 3225.

42. Hansen, J. L.,, P. B. Moore,, and T. A. Steitz. 2003. Structures of five antibiotics bound at the peptidyl transferase center of the large ribosomal subunit. J. Mol. Biol. 330: 1061– 1075.

43. Hansen, J. L.,, J. A. Ippolito,, N. Ban,, P. Nissen,, P. B. Moore,, and T. A. Steitz. 2002. The structures of four macrolide antibiotics bound to the large ribosomal subunit. Mol. Cell 10: 117– 128.

44. Harms, J. M.,, F. Schluenzen,, P. Fucini,, H. Bartels,, and A. E. Yonath. 2004. Alterations at the peptidyl transferase centre of the ribosome induced by the synergistic action of the streptogramins dalfopristin and quinupristin. BMC Biology 2: 4.

45. Haroche, J.,, J. Alligent,, and N. El Solh. 2002. Tn 5406, a new staphylococcal transposon conferring resistance to streptogramin A and related compounds including dalfopristin. Antimicrob. Agents Chemother. 46: 2337– 2343.

46. Hecht, D. W.,, J. S. Thompson,, and M. H. Malamy. 1989. Characterization of the termini and transposition products of Tn 4399, a conjugal mobilizing transposon of Bacteroides fragilis. Proc. Natl. Acad. Sci. 86: 5340– 5344.

46a.. Heir, E.,, B.-A. Lindstedt,, T. M. Leegaard,, E. Gjernes,, and G. Kapperud. 2004. Prevalence and characterization of integrons in blood culture Enterobacteriaceae and gastrointestinal Escherichia coli in Norway and reporting of a novel class I integronlocated lincosamide resistance gene. Ann. Clin. Microbiol. Antimicrob. 3: 12– 20.

47. Hsueh, P.-R.,, L.-J. Teng,, C.-M. Lee,, W.-K. Huang,, T.-L. Wu,, J.-H. Wan,, D. Yang,, J.-M. Shyr,, Y.-C. Chuang,, J.-J. Yan,, J.-J. Lu,, J.-J. Wu,, W.-C. Ko,, F.-Y. Chang,, Y.-C. Yang,, Y.-J. Lau,, Y.-C. Liu,, H.-S. Leu,, C.-Y. Liu,, and K.-T. Luh. 2003. Telithromycin and quinupristin-dalfopristin resistance in clinical isolates of Streptococcus pyogenes: SMART Program 2001 Data. Antimicrob. Agents Chemother. 47: 2152– 2157.

48. Hyde, T. B.,, K. Gay,, D. S. Stephens,, D. J. Vugia,, M. Pass,, S. Johnson,, N. L. Barrett,, W. Schaffner,, P. R. Cieslak,, P. S. Maupin,, E. R. Zell,, J. H. Jorgensen,, R. R. Facklam,, and C. G. Whitney. 2001. Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA 286: 1857– 1862.

49. Iacoviello, V. R.,, and S. H. Zinner,. 2001. Macrolides: a clinical overview, 15– 24. In W. Schonfeld, and H. A. Kirst (ed.), Macrolide Antibiotics. Birkhauser Verlag, Basel, Switzerland.

50. Jaffe, A.,, F. Francis,, M. Rosenthal,, M. Bush. 1998. Longterm azithromycin may improve lung function in children with cystic fibrosis. Lancet 351: 420.

51. Jalava, J.,, J. Kataja,, H. Seppala,, and P. Huovinen. 2001. In vitro activities of the novel ketolide telithromycin (HMR 3647) against erythromycin-resistant Streptococcus species. Antimicrob. Agents Chemother. 45: 789– 793.

52. Jensen, L. B.,, A. M. Hammerum,, R. M,, and F. M. Aarestrup,, A. E. van den Bogaard,, and E. E. Stobberingh. 1998. Occurrence of satA and vgb genes in streptogramin-resistant Enterococcus faecium isolates of animal and human origins in The Netherlands. Antimicrob. Agents Chemother. 42: 3330– 3331.

53. Jensen, L. B.,, A. M. Hammerum,, R. M,, and F. M. Aarestrup. 2000. Linkage of vat(E) and erm(B) in streptogramin-resistant Enterococcus faecium isolates from Europe. Antimicrob. Agents Chemother. 44: 2231– 2232.

54. Jensen, L. B.,, and F. M. Aarestrup. 2001. Macrolide resistance in Campylobacter coli of animal origin in Denmark. Antimicrob. Agents Chemother. 45: 371– 372.

55. Johnson, S. R.,, A. L. Sandul,, M. Parekh,, S. A. Wang,, J. S. Knapp,, and D. L. Trees. 2003. Mutations causing in vitro resistance to azithromycin in Neisseria gonorrhoeae. Int. J. Antimicrob. Agents 21: 414– 419.

56. Jones, R. N.,, P. Della-Latta,, L. V. Lee,, and D. J. Biedenbach. 2002. Linezolid-resistant Enterococcus faecium isolated from a patient without prior exposure to an oxazolidinone: report from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 42: 137– 139.

57. Jost, G. H.,, A. C. Field,, H. T. Trinh,, J. G. Songer,, and S. J. Billington. 2003. Tylosin resistance in Arcanobacterium pyogenes is encoded by an Erm X determinant. Antimicrob. Agents Chemother. 47: 3519– 3524.

58. Jost, G. H.,, H. T. Trinh,, J. G. Songer,, and S. J. Billington. 2004. Ribosomal mutations in Arcanobacterium pyogenes confer a unique spectrum of macrolide resistance. Antimicrob. Agents Chemother. 48: 1021– 1023.

59. Karlsson, M.,, C. Fellstrom,, M. U. Heldtander,, K. E. Johansson,, and A. Franklin. 1999. Genetic basis of macrolide and lin cosamide resistance in Brachyspira (Serpulina) hyodysenteriae. FEMS Microbiol. Lett. 172: 255– 260.

59a.. Karlsson, M.,, C. Fellstrom,, K. E. Johansson,, and A. Franklin. 2004. Antimicrobial resistance in Brachyspira pilosicoli with special reference to point mutations in the 23S rRNA gene associated with macrolide and lincosamide resistance. Microb. Drug Resist. 10: 204– 208.

60. Kamimiya, S.,, and B. Weisblum. 1997. Induction of ermSV by 16-membered-ring macrolide antibiotics. Antimicrob. Agents Chemother. 41: 530– 534.

61. Katayama, J.,, H. Okada,, K. O’Hara,, and N. Noguchi. 1998. Isolation and characterization of two plasmids that mediate macrolide resistance in Escherichia coli: transferability and molecular properties. Biol. Pharm. Bull. 21: 326– 329.

62. Kehoe, L. E.,, J. Snidwongse,, P. Courvalin,, J. B. Rafferty,, and I. A. Murray. 2003. Structural basis of Synercid (quinupristindalfopristin) resistance in gram-positive bacterial pathogens. J. Biol. Chem. 278: 29963– 29970.

63. Kim, Y.-H.,, M.-C. Baek,, S.-S. Choi,, B.-K. Kim,, and E.-C. Choi. 1996. Nucleotide sequence, expression and transcriptional analysis of the Escherichia coli mphK gene encoding macrolide-phosphotransferase K. Mol. Cell 6: 153– 160.

64. Kim, Y.-H.,, C.-J. Cha,, C.-E. Cerniglia. 2002. Purification and characterization of an erythromycin esterase from an erythromycin- resistant Pseudomonas sp. ( ereA). FEMS Microbiol. Lett. 210: 239– 244.

65. Kugler, K. C.,, G. A. Denys,, M. L. Wilson,, and R. N. Jones. 2000. Serious streptococcal infections produced by isolates resistant to streptogramins (quinupristin-dalfopristin): Case reports from the SENTRY antimicrobial surveillance program. Diagn. Microbiol. Infect. Dis. 36: 269– 272.

66. Leclercq, R. 2002. Mechanisms of resistance to macrolides and lincosamides: Nature of the resistance elements and their clinical implications. Clin. Infect. Dis. 34: 482– 492.

67. Leclercq, R.,, and P. Courvalin. 2002. Resistance to macrolides and related antibiotics in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 46: 2727– 2734.

68. Lee, S. Y.,, Y. Ning,, and J. C. Fenno. 2002. 23S rRNA point mutation associated with erythromycin resistance in Treponema denticola. FEMS Microbiol. Lett. 207: 39– 42.

69. Li, X. Z.,, and H. Nikaido. 2004. Efflux-mediated drug resistance in bacteria. Drugs 64: 159– 204.

70. Lina, G.,, A. Quaglia,, M.-E. Reverdy,, R. Leclercq,, R. Vandenesch,, and J. Etienne. 1999. Distribution of genes encoding resistance to macrolides, lincosamides, and streptogramins among staphylococci. Antimicrob. Agents Chemother. 43: 1062– 1066.

71. Liu, M.,, and D. S. Douthwaite. 2002. Activity of the ketolide telithromycin is refractory to erm monomethylation of bacterial rRNA. Antimicrob. Agents Chemother. 46: 1629– 1633.

72. Livermore, D. M. 2003. Linezolid in vitro: mechanism and antibacterial spectrum. J. Antimicrob. Chemother. 51: ii9– ii16.

73. Lucier, T. S.,, K. Heitzman,, K.-K. Liu, and, P.-C. Hu. 1995. Transition mutations in the 23S rRNA of erythromycinresistant isolates of Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 39: 2770– 2773.

74. Luh, K.-T.,, P.-R. Hsueh,, L.-J. Teng,, H.-J. Pan,, Y.-C. Chen,, J.-J. Lu,, J.-J. Wu,, and S.-W. Ho. 2000. Quinupristindalfopristin resistance among gram-positive bacteria in Taiwan. Antimicrob. Agents Chemother. 44: 3374– 3380.

75. Luna, V. A.,, P. Coates,, E. A. Eady,, J. Cove,, T. T. H. Nguyen,, and M. C. Roberts. 1999. A variety of gram-positive bacteria carry mobile mef genes. J. Antimicrob. Chemother. 44: 19– 25.

76. Luna, V. A.,, S. Cousin, Jr., W. L. H. Whittington, and M. C. Roberts. 2000. Identification of the conjugative mef gene in clinical Acinetobacter junii and Neisseria gonorrhoeae isolates. Antimicrob. Agents Chemother. 44: 2503– 2506.

77. Luna, V. A.,, M. Heiken,, K. Judge,, C. Uelp,, N. Van Kirk,, H. Luis,, M. Bernardo,, J. Leitao,, and M. C. Roberts. 2002. Distribution of the mef(A) gene in gram-positive bacteria from healthy Portuguese children. Antimicrob. Agents Chemother. 46: 2513– 2517.

78. MacGowan, A. P. 2003. Pharmacokinetic and pharmacodynamic profile of linezolid in healthy volunteers and patients with gram-positive infections. J. Antimicrob. Chemother. 51: ii17– ii25.

79. Malbruny, B.,, A. Canu,, B. Bozdogan,, B. Fantin,, V. Zarrouk,, S. Dutka-Malen,, C. Feger,, and R. Leclercq. 2002. Resistance to quinupristin-dalfopristin due to mutations of L22 ribosomal protein in Staphylococcus aureus. Antimicrob. Agents Chemother. 46: 2200– 2207.

80. Malbruny, B.,, K. Nagai,, M. Coquemont,, B. Bozdogan,, A. T. Andrasevic,, H. Hupkova,, R. Leclercq,, and P. C. Appelbaum. 2002. Resistance to macrolides in clinical isolates of Streptococcus pyogenes due to ribosomal mutations. J. Antimicrob. Chemother. 49: 935– 939.

80a.. Malbruny B.,, A. M. Werno,, T. P. Anderson,, D. R. Murdoch,, and R. Leclercq. 2004. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand. J. Antimicrob. Chemother. 54: 1040– 1044.

81. Marshall, S. H.,, C. J. Donskey,, R. Hutton-Thomas,, R. A. Salata,, and L. B. Rice. 2002. Gene dosage and linezolid resistance in Enterococcus faecium and Enterococcus faecalis. Antimicrob. Agents Chemother. 46: 3334– 3336.

82. Martel, A.,, V. Meulenaere,, L. A. Devriese,, A. Decostere,, and F. Haesebrouck. 2003. Macrolide- and lincosamide-resistance in the gram-positive nasal and tonsillar flora of pigs. Microbial Drug Res. 9: 293– 297.

83. Matsuoka, M.,, K. Endou,, H. Kobayashi,, M. Inoue,, and Y. Nakajima. 1997. A dyadic plasmid that shows MLS and PMS resistance in Staphylococcus aureus. FEMS Microbiol. Lett. 148: 91– 96.

84. Matsuoka, M.,, M. Inoue,, Y. Nakajima,, and K. Endou. 2002. New erm gene in Staphylococcus aureus clinical isolates. Antimicrob. Agents Chemother. 46: 211– 215.

85. McDougal, L. K.,, F. C. Tenover,, L. N. Lee,, J. K. Rasheed,, J. E. Patterson,, J. H. Jorgensen,, and D. J. LeBlanc. 1998. Detection of Tn 917-like sequences within a Tn 916-like conjugative transposon (Tn 3872) in erythromycin-resistant isolates of Streptococcus pneumoniae. Antimicrob. Agents Chemother. 42: 2312– 2318.

86. Meka, V. G.,, S. K. Pillai,, G. Sakoulas,, C. Wennersten,, L. Venkataraman,, P. C. Degirolami,, G. M. Eliopoulos,, R. C. Moellering, Jr., and H. S. Gold. 2004. Linezolid resistance in sequential Staphylococcus aureus isolates associated with a T2500A mutation in the 23S rRNA gene and loss of a single copy of rRNA. J. Infect. Dis. 190: 311– 317.

87. Misyurina, O. Y.,, E. V. Chipitsyna,, Y. P. Finashutina,, V. N. Lazarev,, T. A. Akopian,, A. M. Savicheva,, and V. M. Govorun. 2004. Mutations in a 23S rRNA gene of Chlamydia trachomatis associated with resistance to macrolides. Antimicrob. Agents Chemother. 48: 1347– 1349.

87a.. Moore, P. B.,, and T. A Steitz. 2003. The structural basis of large ribosomal subunit function. Annu. Rev. Biochem. 72: 813– 850.

88. Mukhtar, T. A.,, K. P. Koteva,, D. W. Hughes,, and G. D. Wright. 2001. Vgb from Staphylococcus aureus inactivates streptogramin B antibiotics by an elimination mechanism not hydrolysis. Biochem. 40: 8877– 8886.

89. Muller-Serieys, C.,, J. Andrews,, F. Vacheron,, and C. Cantalloube. 2004. Tissue kinetics of telithromycin, the first ketolide antibacterial. J. Antimicrob. Chemother. 53: 149– 157.

90. Mutnick, A. H.,, V. Enne,, and R. N. Jones. 2003. Linezolid resistance since 2001: SENTRY antimicrobial surveillance program. Ann. Pharmacother. 37: 769– 774.

91. Nakamura, A.,, I. Miyakozawa,, K. Nakazawa,, K. O’Hara,, and T. Sawai. 2000. Detection and characterization of a macrolide 2′-phosphotransferase from a Pseudomonas aeruginosa clinical isolated. Antimicrob. Agents Chemother. 44: 3241– 3242.

92. Nash, K. A.,, and C. B. Inderlied. 1996. Rapid detection of mutations associated with macrolide resistance in Mycobacterium avium complex. Antimicrob. Agents Chemother. 40: 1748– 1750.

93. Nash, K. A. 2003. Intrinsic macrolide resistance in Mycobacterium smegmatis is conferred by a novel erm gene, erm(38). Antimicrob. Agents Chemother. 47: 3053– 3060.

94. Nash, K. A.,, Y. Zhang,, B. A. Brown-Elliott,, R. J. Wallace, Jr. 2004. Identification of an rRNA methylase gene, erm(39), which confers inducible macrolide resistance to M. fortuitum, abstr. U-017. In Program and Abstracts of the 104th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.

95. Ng, L. K.,, I. Martin,, G. Liu,, and L. Bryden. 2002. Mutations in 23S rRNA associated with macrolide resistance in Neisseria gonorrhoeae. Antimicrob. Agents Chemother. 46: 3020– 5025.

96. Niwa, H.,, T. Chuma,, K. Okamoto,, and K. Itoh. 2001. Rapid detection of mutations associated with resistance to erythromycin Campylobacter jejuni/coli by PCR and line probe assay. Int. J. Antimicrob. Agents 18: 359– 364.

97. Noguchi, N.,, A. Emura,, H. Matsuyama,, K. O’Hara,, M. Sasatsum,, and M. Kono. 1995. Nucleotide sequence and characterization of erythromycin resistance determinant that encodes macrolide 2′-Phosphotransferase I in Escherichia coli. Antimicrob. Agents Chemother. 39: 2359– 2363.

98. Noguchi, N.,, J. Katayama,, and M. Sasatsu. 2000. A transposon carrying the gene mphB for macrolide 2′-phosphotransferase II. FEMS Microbiol. Lett. 192: 175– 178.

99. Noguchi, N.,, Y. Tamura,, J. Katayama,, and K. Narui. 1998. Expression of the mphB gene for macrolide 2′-phosphotransferase II from Escherichia coli in Staphylococcus aureus. FEMS Microbiol. Lett. 159: 337– 342.

100. Ojo, K. K.,, C. Ulep,, N. Van Kirk,, H. Luis,, M. Bernardo,, J. Leitao,, and M. C. Roberts. 2004. The mef(A) gene predominates among seven macrolide resistant genes identified in 13 gram-negative genera from healthy Portuguese children. Antimicrob. Agents Chemother. 48: 3451– 3456.

101. Paterson, D. L.,, A. W. Pasculle,, and K. McCurry. 2003. Linezolid: the first oxazolidinone antimicrobial. Ann. Intern. Med. 139: 863– 864.

102. Pereyre, S.,, P. Gonzalez,, B. de Barbeyrac,, A. Darnige,, H. Renaudin,, A. Charron,, S. Raherison,, C. Bebear,, and C. M. Bebear. 2002. Mutations in 23S rRNA account for intrinsic resistance to macrolides in Mycoplasma hominis and Mycoplasma fermentans and for acquire resistance to macrolides in M. hominis. Antimicrob. Agents Chemother. 46: 3142– 3150.

103. Pereyre, S.,, C. Guyot,, H. Renaudin,, A. Charron,, C. Bebear,, and C. M. Bebear. 2004. In vitro selection and characterization of resistance to macrolides and related antibiotics in Mycoplasma pneumoniae. Antimicrob. Agents Chemother. 48: 460– 465.

103a.. Peric, M.,, B. Bozdogan,, M. R. Jacobs,, and P. C. Appelbaum. 2003. Effects of an efflux mechanism and ribosomal mutations on macrolide susceptibility of Haemophilus influenzae clinical isolates. Antimicrob. Agents Chemother. 47: 1017– 1022.

104. Plante, I.,, D. Centron,, and P. H. Roy. 2003. An susceptible cassette encoding erythromycin esterase, ere(A), from Providencia stuartii. Antimicrob. Agents Chemother. 51: 787– 790.

105. Poehlsgaard, J.,, and S. Douthwaite. 2003. Macrolide antibiotic interaction and resistance on the bacterial ribosome. Cur. Opin. Invest. Drugs. 4: 140– 148.

106. Porse, B. T.,, and R. A. Garrett. 1999. Sites of interaction of streptogramin A and B antibiotics in the peptidyl transferase loop of 23S rRNA and the synergism of their inhibitory mechanisms. J. Mol. Biol. 286: 275– 387.

107. Prunier, A. L.,, B. Malbruny,, D. Tande,, B. Picard,, and R. Leclercq. 2002. Clinical isolates of Staphylococcus aureus with ribosomal mutations conferring resistance to macrolides. Antimicrob. Agents Chemother. 46: 3054– 3056.

107a.. Prunier, A. L.,, H. N. Trong,, D. Tande,, C. Segond,, and R. Leclercq. 2005. Mutation of L4 ribosomal protein conferring unusual macrolide resistance in two independent clinical isolates of Staphylococcus aureus. Microb. Drug Resist. 11: 18– 20.

107b.. Prystowsky, J.,, F. Siddiqui,, J. Chosay,, D. L. Shinabarger,, J. Millichap,, L. R. Peterson,, and G. A. Noskin. 2001. Resistance to linezolid: characterization of mutations in rRNA and comparison of their occurrences in vancomycin-resistant enterococci. Antimicrob. Agents Chemother. 45: 2154– 2156.

108. Rahim, S.,, S. K. Pillai,, H. S. Gold,, L. Venkataraman,, K. Inglima,, and R. A. Press. 2003. Linezolid-resistant, vancomycinresistant Enterococcus faecium infection in patients without prior exposure to linezolid. Clin. Infect. Dis. 36: e146– e148.

109. Reinert, R. R.,, R. Lutticken,, J. A. Sutcliffe,, A. Tait-Kamradt,, M. Y. Cil,, H. M. Schorn,, A. Bryskier,, and A. Al-Lahham. 2004. Clonal relatedness of erythromycin-resistant Streptococcus pyogenes isolates in Germany. Antimicrob. Agents Chemother. 48: 1369– 1373.

110. Reinert, R. R.,, A. Wild,, P. Appelbaum,, R. Lutticken,, M. Y. Cil,, and A. Al-Lahham. 2003. Ribosomal mutations conferring resistance to macrolides in Streptococcus pneumoniae clinical strains isolated in Germany. Antimicrob. Agents Chemother. 47: 2319– 2322.

111. Reynolds, E.,, J. I. Ross,, and J. H. Cove. 2003. msr(A) and related macrolide/streptogramin resistance determinants: incomplete transporters? Int. J. Antimicrob. Agents. 22: 228– 236.

112. Rice, L. B. 1998. Tn 916 family conjugative transposons and dissemination of antimicrobial resistance determinants. Antimicrob. Agents Chemother. 42: 1871– 1877.

113. Roberts, M. C., 1989. Gene transfer in the urogenital and respiratory tract, p. 347– 375. In S. B. Levy, and R. V. Miller (ed.), Gene Transfer in the Environment. McGraw-Hill Publishing Co., New York, N.Y.

114. Roberts, M. C.,, and M. B. Brown. 1994. Macrolidelincosamide resistance determinants in streptococcal species isolated from the bovine mammary gland. Vet. Microbiol. 40: 253– 261.

115. Roberts, M. C.,, J. Sutcliffe,, P. Courvalin,, L. B. Jensen,, J. Rood,, and H. Seppala. 1999. Nomenclature for macrolide and macrolide-lincosamide streptogramin B antibiotic resistance determinants. Antimicrob. Agents Chemother. 43: 2823– 2830.

116. Ross, J. I.,, A. M. Snelling,, E. A. Eady,, J. H. Cove,, W. J. Cunliffe,, J. J. Leyden,, P. Collignon,, B. Dreno,, A. Reynaud,, J. Fluhr,, and S. Oshima. 2001. Phenotypic and genotypic characterization of antibiotic-resistant Propionibacterium acnes isolated from acne patients attending dermatology clinics in Europe, the U.S.A., Japan and Australia. Br. J. Dermatol. 144: 339– 346.

117. Saiman, L.,, Y. Chen,, P. San Gabriel,, C. Knirsch. 2002. Synergistic activities of macrolide antibiotics against Pseudomonas aeruginosa, Burkholderia cepacia, Stenotrophomonas maltophilia, and Alcaligenes xylosoxidans isolated from patients with cystic fibrosis. Antimicrob. Agents Chemother. 46: 1105– 1107.

118. Saiman, L.,, B. C. Marshall,, N. Mayer-Hamblett,, J. L. Burns,, A. L. Quittner,, D. A. Cibene,, S. Coquillette,, A. Y. Fieberg,, F. J. Accurso,, P. W. Campbell III,. 2003. Azithromycin in patients with cystic fibrosis chronically infected with Pseudomonas aeruginosa: a randomized controlled trial. JAMA 290: 1749– 1756.

119. Sanchez, L.,, W. Pan,, M. Vinas,, and H. Nicaido. 1997. The acrAB homology of Haemophilus influenzae codes of a functional multidrug efflux pump. J. Bacteriol. 179: 6855– 6857.

120. Santagati, M.,, F. Iannelli,, C. Cascone,, F. Campanile,, M. R. Oggioni,, S. Sefani,, and F. Pozzi. 2003. The novel conjugative transposon Tn 1207.3 carries the macrolide efflux gene mef(A) in Streptococcus pyogenes. Microb. Drug Res. 9: 243– 247.

121. Schlunzen, F.,, J. M. Harms,, F. Franceschi,, H. A. Hansen,, H. Bartels,, E. Zarivach,, and A. Yonath. 2003. Structural basis for the antibiotic activity of ketolides and azalides. Structure 11: 329– 338.

122. Schlunzen, F.,, R. Zarivach,, J. Harms,, A. Bashan,, A. Tocilj,, R. Albrecht,, A. Yonath,, and F. Franceschi. 2001. Structural basis for the interaction of antibiotics with the peptidyl transferase centre in eubacteria. Nature 413: 814– 821.

123. Schmitz, F.-J.,, J. Petridou,, H. Jagusch,, N. Astfalk,, S. Scheuring,, and S. Schwarz. 2002. Molecular characterization of ketolide- resistance erm(A)-carrying Staphylococcus aureus isolates selected in vitro by telithromycin, ABT-773, quinupristin and clindamycin. J. Antimicrob. Chemother. 49: 611– 617.

123a.. Schmitz, F. J.,, J. Petridou,, A. C. Fluit,, U. Hadding,, G. Peters,, and C. von Eiff. 2000. Distribution of macrolide-resistance genes in Staphylococcus aureus blood-culture isolates from fifteen German university hospitals. M.A.R.S. Study Group. Multicentre Study on Antibiotic Resistance in Staphylococci. Eur. J. Clin. Microbiol. Infect. Dis. 19: 385– 387.

123b.. Schmitz, F. J.,, R. Sadurski,, A. Kray,, M. Boos,, R. Geisel,, K. Kohrer,, J. Verhoef,, and A. C. Fluit. 2000. Prevalence of macrolide-resistance genes in Staphylococcus aureus and Enterococcus faecium isolates from 24 European university hospitals. J. Antimicrob. Chemother. 45: 891– 894.

124. Schmitz, F.-J.,, W. Witte,, G. Werner,, J. Petridou,, A. C. Fluit,, and S. Schwarz. 2001. Characterization of the translational attenuator of 20 methicillin-resistant, quinupristin/dalfopristinresistant Staphylococcus aureus isolates with reduced susceptibility to glycopeptides. J. Antimicrob. Chemother. 48: 939– 941.

125. Schwarz, S.,, C. Kehrenberg,, and K. K. Ojo. 2002. Staphylococcus sciuri gene erm(33), encoding inducible resistance to macrolides, lincosamides, and streptogramin B antibiotics, is a product of recombination between erm( R) and erm(A). Antimicrob. Agents Chemother. 46: 3621– 3623.

126. Seoane, A.,, and J. M. G. Lobo. 2000. Identification of a streptogramin A acetyltransferase gene in the chromosome of Yersinia enterocolitica. Antimicrob. Agents Chemother. 44: 905– 909.

127. Seppala, H.,, T. Klaukka,, J. Vuopio-Varkila,, A. Muotiala,, H. Helenius,, K. Lager,, P. Huovinen. 1997. The effect of changes in the consumption of macrolide antibiotics on erythromycin resistance in Group A streptococci in Finland. N. Engl. J. Med. 337: 441– 446.

128. Shafer, W. M.,, J. T. Balthazar,, K. E. Hagman,, and S. A. Morse. 1999. Missense mutations that alter the DNA-binding domain of the MtrR protein occur frequently in rectal isolates of Neisseria gonorrhoeae that are resistant to faecal lipids. Microbiology 141: 907– 911.

129. Shoemaker, N. B.,, H. Vlamikis,, K. Hayes,, and A. A. Salyers. 2001. Evidence for extensive resistance gene transfer among Bacteroides spp. and between Bacteroides and other genera in the human colon. Appl. Environ. Microbiol. 67: 561– 568.

130. Shortridge, V. D.,, G. V. Doern,, A. B. Brueggmann,, J. M. Beyer,, and R. K. Flamm. 1999. Prevalence of macrolide resistance mechanism in Streptococcus pneumoniae isolates from a multi-center susceptible resistance surveillance study conducted in the United States in 1994-1995. Clin. Infect. Dis. 29: 1186– 1188.

131. Sinclair, A.,, C. Arnold,, and N. Woodford. 2003. Rapid detection and estimation by pyrosequencing of 23S rRNA genes with a single nucleotide polymorphism conferring linezolid resistance in enterococci. Antimicrob. Agents Chemother. 47: 3620– 3622.

132. Speciale, A.,, K. La Ferla,, F. Caccamo,, and G. Nicoletti. 1999. Antimicrobial activity of quinupristin/dalfopristin, a new injectable streptogramin with wide gram-positive spectrum. Int. J. Antimicrob. Agents 13: 21– 28.

133. Stanton, T. B.,, and S. B. Humphrey. 2003. Isolation of tetracycline- resistant Megasphaera elsdenii strains with novel mosaic gene combinations of tet(O) and tet(W) from swine. Appl. Environ. Microbiol. 69: 3874– 3882.

134. Sugantino, M.,, and S. L. Roderick. 2002. Crystal structure of Vat(D): an acetyltransferase that inactivates streptogramin group A antibiotics. Biochemistry 41: 2209– 2216.

135. Sutcliffe, J. A.,, and R. Leclercq,. 2003. Mechanisms of resistance to macrolides, lincosamides and ketolides, p. 281– 317. In W. Schonfeld, and H. A. Kirst (ed.), Macrolide Antibiotics. Birkhauser Verlag, Basel, Switzerland.

135a.. Swaney, S. M.,, D. L. Shinabarger,, R. D. Schaadt,, J. H. Bock,, J. L. Slightom,, and G. E. Zurenko. 1998. Oxazolidinone resistance is associated with a mutation in the peptidyl transferase region of 23S rRNA, abstr. C-104. In Proceedings of the 38th Interscience Conference on Antimicrobial Agents and Chemotherapy American Society for Microbiology, Washington, D.C.

136. Tait-Kamradt, A.,, J. Clancy,, M. Cronan,, F. Dib-Hajj,, L. Wondrack,, W. Yan,, and J. Sutcliffe. 1997. mefE is necessary for the erythromycin-resistant M phenotype in Streptococcus pneumoniae. Antimicrob. Agents Chemother. 41: 2251– 2255.

137. Tait-Kamradt, A.,, T. Davies,, P. C. Appelbaum,, F. Depardieu,, P. Courvalin,, J. Pettipas,, L. Wondrack,, A. Walker,, M. R. Jacobs,, and J. Sutcliffe. 2000. Two new mechanisms of macrolide resistance in clinical strains of Streptococcus pneumoniae from Eastern Europe and North America. Antimicrob. Agents Chemother. 44: 3395– 3401.

138. Tait-Kamradt, A.,, T. Davies,, M. Cronan,, M. R. Jacobs,, P. C. Appelbaum,, and J. Sutcliffe. 2000. Mutations in 23S rRNA and L4 ribosomal protein account for resistance in pneumococcal strains selected in vitro by macrolide passage. Antimicrob. Agents Chemother. 44: 2118– 2125.

139. Tait-Kamradt, A.,, R. R. Reinert,, A. Al-Lahham,, D. E. Low,, and J. A. Sutcliffe. 2001. High-level ketolide-resistant streptococci, p. 101. In Program and Abstracts of the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.

140. Taniguchi, L.,, A. Nakamura,, K. Tsurubuchi,, A. Ishii,, K. O’Hara,, and T. Sawai. 1999. Identification of functional amino acids in the macrolide 2″ phosphtransferase II. Antimicrob. Agents Chemother. 43: 2063– 2065.

141. Tateda, K.,, Y. Ishii,, T. Matsumoto,, N. Furuya,, M. Nagashima,, T. Matsunaga,, A. Onho,, S. Miyazaki,, and K. Yamaguchi. 1996. Direct evidence for antipseudomonal activity of macrolides: exposure- dependent bactericidal activity and inhibition of protein synthesis by erythromycin, clarithromycin, and azithromycin. Antimicrob. Agents Chemother. 40: 2271– 2275.

142. Taylor, D. E.,, Z. Ge,, D. Purych,, T. Lo,, and K. Hiratsuka. 1997. Cloning and sequence analysis of two copies of a 23S rRNA gene from Helicobacter pylori and association of clarithromycin resistance with 23S rRNA mutations. Antimicrob. Agents Chemother. 43: 2621– 2628.

143. Teng, L.-J.,, P.-R. Hsueh,, J.-C. Tsai,, S.-J. Liaw,, S.-W. Ho,, and K.-T. Luh. 2002. High incidence of cefoxitin and clindamycin resistance among anaerobes in Taiwan. Antimicrob. Agents Chemother. 46: 2908– 2913.

144. Tenson, T.,, M. Lovmar,, and M. Ehrenbert. 2003. The mechanism of action of macrolides, lincosamides and streptogramin B reveals the nascent peptide exit path in the ribosome. J. Mol. Biol. 330: 1005– 1014.

145. Thungapathra, M.,, K. K. Amita,, K. K. Sinha,, S. R. Chaudhuri,, P. Garg,, T. Ramamurthy,, G. B. Nair,, and A. Ghosh. 2002. Occurrence of antibiotic resistance gene cassettes aac( 6′)- Ib, dfrA5, dfrA12, and ereA2 in Class I integrons in Non-O1, Non-O139 Vibrio cholerae strains in India. Antimicrob. Agents Chemother. 46: 2948– 2955.

146. Tomasz, A. 1999. New faces of an old pathogen: emergence and spread of a multidrug-resistant Streptococcus pneumoniae. Am. J. Med. 107: 55S– 66S.

147. Tsiodras, S.,, H. S. Gold,, G. Sakoulas,, G. M. Eliopoulos,, C. Wennersten,, L. Vendataraman,, R. C. Moellering,, and M. J. Ferraro. 2001. Linezolid resistance in a clinical isolate of Staphylococcus aureus. Lancet 358: 207– 208.

147a.. Tu, D.,, G. Blaha,, P. B. Moore,, and T. A. Steitz. 2005. Structures of MLSBK antibiotics bound to mutated large ribosomal subunits provide a structural explanation for resistance. Cell 121: 257– 270.

148. Valentine, P. J.,, N. B. Shoemaker,, and A. A. Salyers. 1988. Mobilization of Bacteroides plasmids by Bacteroides conjugal elements. J. Bacteriol. 170: 1319– 1324.

149. Vera-Cabrera, L.,, A. Gomez-Flores,, W. G. Escalante-Fuentes,, and O. Welsh. 2001. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Norcardia brasiliensis. Antimicrob. Agents Chemother. 45: 3629– 2620.

150. Vester, B.,, and S. Douthwaite. 2001. Macrolide resistance conferred by base substitutions in 23S rRNA. Antimicrob. Agents Chemother. 45: 1– 12.

151. Villedieu, A.,, H. A. Hussain,, M. Wilson,, and P. Mullany. 2004. Identification of an oral tet(W) gene contained within a novel transposon-like structure, abstr. H-114. In Program and Abstracts of the 104th General Meeting of the American Society for Microbiology. American Society for Microbiology, Washington, D.C.

152. Waites, K.,, C. Johnson,, B. Gray,, K. Edwards,, M. Crain,, and W. Benjamin, Jr. 2000. Use of clindamycin disks to detect macrolide resistance mediated by ermB and mefE in Streptococcus pneumoniae isolates from adults and children. J. Clin. Microbiol. 38: 1731– 1734.

153. Wang, Y.,, G. R. Wang,, A. Shelby,, N. B. Shoemaker,, and A. A. Salyers. 2003. A newly discovered Bacteroides conjugative transposon, CTnGERM1, contains genes also found in gram-positive bacteria. Appl. Environ. Microbiol. 69: 4594– 4603.

153a.. Wareham, D. W.,, M. Wilks,, D. Ahmed,, J. S. Brazier,, and M. Miller. 2005. Anaerobic sepsis due to multidrug-resistant Bacteroides fragilis: microbiological cure and clinical response with linezolid therapy. Clin. Infect. Dis. 40: e67– e68.

154. Wasteson, Y.,, D. E. Roe,, K. Falk,, and M. C. Roberts. 1996. Characterization of antibiotic resistance in Actinobacillus pleuropneumoniae. Vet. Microbiol. 48: 41– 50.

155. Webber, M. A.,, and L. J. V. Piddock. 2003. The importance of efflux pumps in bacterial antibiotic resistance. J. Antimicrob. Chemother. 51: 9– 11

156. Werner, G.,, C. Cuny,, F.-J. Schmitz,, and W. Witte. 2001. Methicillin- resistant, quinupristin-dalfopristin-resistant Staphylococcus aureus with reduced sensitivity to glycopeptides. J. Clin. Microb. 39: 3586– 3590.

157. Werner, G.,, I. Klare,, and W. Witte. 2002. Molecular analysis of streptogramin resistance in enterococci. Int. J. Med. Microbiol. 292: 81– 94.

158. Wilcox, M. H. 2003. Efficacy of linezolid versus comparator therapies in gram-positive infections. J. Antimicrob. Chemother. 51(Suppl. S2): ii27– ii35.

159. Wilson, P.,, J. A. Andrews,, R. Charlesworth,, R. Walesby,, M. Singer,, D. J. Farrell,, and M. Robbins. 2003. Linezoid resistance in clinical isolates of Staphylococcus aureus. J. Antimicrob. Chemother. 51: 186– 188.

159a.. Wimberly, B. D., 2003. Crystal structure of the ribosome and ribosomal subunits, p. 237– 246. In L. Brakier-Gingras, and J. Lapointe (ed.), Translation Mechanisms. Landes Bioscience/ Eurekah, Georgetown, Tex., and Kluwer Academic/Plenum Publishers.

160. Wondrack, L.,, M. Massa,, B. V. Yang,, and J. Sutcliffe. 1996. Clinical strain of Staphylococcus aureus inactivates and causes efflux of macrolides. Antimicrob. Agents Chemother. 40: 992– 998.

161. Woodford, N.,, L. Tysall,, C. Auckland,, M. W. Stockdale,, A. J. Lawson,, R. A. Walkerm,, and D. M. Livermore. 2002. Detection of oxazolidinone-resistant Enterococcus faecalis and Enterococcus faecium strains by real-time PCR and PCRrestriction fragment length polymorphism analysis. J. Clin. Microbiol. 40: 298– 4300.

162. Yagi, B. H.,, and G. E. Zurenko. 2003. An in vitro time-kill assessment of linezolid and anaerobic bacteria. Anaerobe 9: 1– 3.

163. Zarantonelli, L.,, G. Borthagaray,, E. H. Lee,, W. Veal,, and W. M. Shafer. 2001. Decrease susceptibility to azithromycin and erythromycin mediated by a novel mtr(R) promoter mutation in Neisseria gonorrhoeae. J. Antimicrob. Chemother. 47: 651– 654.

164. Zurenko, G. E.,, W. M. Todd,, B. Hafkin,, B. Meyers,, C. Kauffman,, and J. Bock, et al. 1999. Development of linezolidresistant Enterococcus faecium in two compassionate use program patients treated with linezolid, abstr. C-848. In Proceedings of the 39th Interscience Conference on Antimicrobial Agents and Chemotherapy. American Society for Microbiology, Washington, D.C.

Tables

Macrolide, Lincosamide, Streptogramin, Ketolide, and Oxazolidinone Resistance

/content/10.1128/9781555817572.chap6.tab6-1

Table 1

Mechanism of resistance a

a http://faculty.washington.edu/marilynr.

b See reference 27.

c See reference 80a.

d See reference 46a.

10.1128/9781555817572/tab6-1_thmb.gif

10.1128/9781555817572/tab6-1.gif

Table 1

Mechanism of resistance a

a http://faculty.washington.edu/marilynr.

b See reference 27.

c See reference 80a.

d See reference 46a.

/content/10.1128/9781555817572.chap6.tab6-2

Table 2

Bacteria carrying specific resistance genes a

a The erm(B) gene is the only rRNA methylase screened for in enteric gram-negative bacteria. Thus the distribution of other erm genes in aerobic gram-negative genera is most likely underrepresented in the table.

b http://faculty.washington.edu/marilynr. This website is updated yearly.

c Macrolide-lincosamide-streptogramin B resistance.

d Resistance to either lincomycin, oleandomycin, spriamycin, tylosin, or streptogramin A or both erythromycin and streptogramin B.

e Reference 153, the msr(D) gene may not be functional.

f Resistance to either lincomycin or erythromycin.

g The mef(A) gene produces a truncated protein which is missing N-terminal amino acids and most likely is not functional.

h Resistance to erythromycin.

i Resistance to streptogramin B.

j Resistance to either lincomycin or streptogramin A.

k Resistance to macrolides.

10.1128/9781555817572/tab6-2_thmb.gif

10.1128/9781555817572/tab6-2.gif

Table 2

Bacteria carrying specific resistance genes a

b http://faculty.washington.edu/marilynr. This website is updated yearly.

c Macrolide-lincosamide-streptogramin B resistance.

d Resistance to either lincomycin, oleandomycin, spriamycin, tylosin, or streptogramin A or both erythromycin and streptogramin B.

e Reference 153, the msr(D) gene may not be functional.

f Resistance to either lincomycin or erythromycin.

g The mef(A) gene produces a truncated protein which is missing N-terminal amino acids and most likely is not functional.

h Resistance to erythromycin.

i Resistance to streptogramin B.

j Resistance to either lincomycin or streptogramin A.

k Resistance to macrolides.

/content/10.1128/9781555817572.chap6.tab6-3

Table 3

Species identified with 23S rRNA, L4, and/or L22 ribosomal protein mutations conferring resistance to MLSKO antibiotics a

a Data from references 11 , 18a , 30 , 35 , 54 , 59a , 62 , 79 - 80 , 86 , 95 , 96 , 102a , 103 , 106 , 107a , 135 , 138 , 139 , 142 , and 163 .

b At either the A2058 or A2059 position with E. coli numbering

10.1128/9781555817572/tab6-3_thmb.gif

10.1128/9781555817572/tab6-3.gif

Table 3

Species identified with 23S rRNA, L4, and/or L22 ribosomal protein mutations conferring resistance to MLSKO antibiotics a

a Data from references 11 , 18a , 30 , 35 , 54 , 59a , 62 , 79 - 80 , 86 , 95 , 96 , 102a , 103 , 106 , 107a , 135 , 138 , 139 , 142 , and 163 .

b At either the A2058 or A2059 position with E. coli numbering

/content/10.1128/9781555817572.chap6.tab6-4

Table 4

MLSKO antibiotic resistance genes linked to other antibiotic resistance genes or elements a

a This table is meant to illustrate the diversity of the genes and elements that the MLS genes have been linked to ( 2 – 5 , 16 , 27 , 38 , 40 , 43 , 45 , 52 , 53 , 83 , 85 , 104 , 112 , 120 , 145 , 153 ).

b The mef(A) and the msr(D) genes appear to be together in all clinical isolates examined from any genera; however, when cloned separately into naive strains of S. pneumoniae, both conferred macrolide resistance alone ( 27 ).

c Integron codes for an integrase (IntI) that mediates recombination between a recombination site (attI) and a target recombination sequence (attC; 59-base element.).

d Required for high level erythromycin resistance in E. coli.

10.1128/9781555817572/tab6-4_thmb.gif

10.1128/9781555817572/tab6-4.gif

Table 4

MLSKO antibiotic resistance genes linked to other antibiotic resistance genes or elements a

c Integron codes for an integrase (IntI) that mediates recombination between a recombination site (attI) and a target recombination sequence (attC; 59-base element.).

d Required for high level erythromycin resistance in E. coli.